Clinical Trials in Ephrata, United States
Locations / Ephrata, United States
Delta Trials records 164 clinical trials conducted in Ephrata, United States, making it a notable site of clinical research activity. These trials across 498 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 14 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Ephrata has changed over time.
164
Total Trials
498
Conditions
14
Terminated since 2020
Browse by condition (498 total)
- Stage iv lung cancer ajcc v8 15 trialsAll Stage iv lung cancer ajcc v8 trials
- Breast cancer 12 trialsAll Breast cancer trials
- Recurrent squamous cell lung carcinoma 10 trialsAll Recurrent squamous cell lung carcinoma trials
- All Recurrent lung non-small cell carcinoma trials
- All Stage iv squamous cell lung carcinoma ajcc v7 trials
- Stage ivb lung cancer ajcc v8 7 trialsAll Stage ivb lung cancer ajcc v8 trials
- Stage iva lung cancer ajcc v8 7 trialsAll Stage iva lung cancer ajcc v8 trials
- Invasive breast carcinoma 5 trialsAll Invasive breast carcinoma trials
- All Anatomic stage ii breast cancer ajcc v8 trials
- Stage iiib lung cancer ajcc v8 5 trialsAll Stage iiib lung cancer ajcc v8 trials
- All Extensive stage lung small cell carcinoma trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Stage iiia breast cancer 4 trialsAll Stage iiia breast cancer trials
- Lung non-small cell carcinoma 4 trialsAll Lung non-small cell carcinoma trials
- Prostate adenocarcinoma 4 trialsAll Prostate adenocarcinoma trials
- Breast carcinoma 4 trialsAll Breast carcinoma trials
- Colorectal cancer 4 trialsAll Colorectal cancer trials
- Stage ii breast cancer 4 trialsAll Stage ii breast cancer trials
- All Recurrent lung non-squamous non-small cell carcinoma trials
- Recurrent ovarian carcinoma 4 trialsAll Recurrent ovarian carcinoma trials